Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68767-14-6

Post Buying Request

68767-14-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68767-14-6 Usage

Description

Loxoprofen is a non-selective nonsteroidal anti-inflammatory drug (NSAID) that is a monocarboxylic acid derivative of propionic acid. It features a 4-[(2-oxocyclopentyl)methyl]phenyl group substitution at the 2nd hydrogen position. Loxoprofen is a prodrug that becomes active after metabolism in the body, where it inhibits the activation of cyclooxygenase, thus reducing inflammation.

Uses

Used in Pharmaceutical Industry:
Loxoprofen is used as an anti-inflammatory agent for reducing inflammation and pain. It is particularly effective in treating conditions such as arthritis and other inflammatory disorders.
Used in Cardiovascular Applications:
Loxoprofen is used as an anti-atherosclerotic agent for reducing atherosclerosis in mice by lowering inflammation levels, which can contribute to the hardening of the arteries and increase the risk of cardiovascular diseases.
Used in Pain Management:
Loxoprofen is used as an analgesic for managing mild to moderate pain, such as headaches, muscle aches, and joint pain, by reducing inflammation and providing relief from discomfort.

Check Digit Verification of cas no

The CAS Registry Mumber 68767-14-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,7,6 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 68767-14:
(7*6)+(6*8)+(5*7)+(4*6)+(3*7)+(2*1)+(1*4)=176
176 % 10 = 6
So 68767-14-6 is a valid CAS Registry Number.
InChI:InChI=1/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)

68767-14-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (L0244)  Loxoprofen  >97.0%(HPLC)(T)

  • 68767-14-6

  • 5g

  • 1,490.00CNY

  • Detail
  • Sigma

  • (L0664)  Loxoprofen  solid

  • 68767-14-6

  • L0664-5MG

  • 3,192.93CNY

  • Detail

68767-14-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name loxoprofen

1.2 Other means of identification

Product number -
Other names IOXOPROFEN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68767-14-6 SDS

68767-14-6Relevant articles and documents

Synthetic method of loxoprofen

-

Paragraph 0034; 0083; 0089-0090; 0095; 0100-0101, (2020/08/02)

The invention discloses a synthetic method of an intermediate loxoprofen for preparing a phenylpropionic acid non-steroidal anti-inflammatory drug loxoprofen sodium. The synthetic method comprises thefollowing steps: firstly, carrying out acylation reaction on a compound VII and a compound VIII in a solvent 1 under the action of lewis acid serving as a catalyst to obtain an intermediate compoundIX; and introducing hydrogen into the intermediate compound IX in a solvent 2 under the action of strong acid by taking palladium on carbon as a catalyst, and carrying out hydrogenation tert-butyl ester removal reaction to obtain loxoprofen. The synthetic method has the advantages that the synthetic route is short, simple in process and convenient to operate, no corrosive strong acid is used in the synthesis process, and the reaction control temperature in the synthesis process is relatively mild; and the synthetic method has the characteristics of no product carbonization, no corrosion to equipment, safe and environment-friendly synthesis process, suitability for industrial production and the like, and the finally obtained product loxoprofen has high yield which can reach 65.8-73.3% and purity of 99.54-99.69% from the beginning of the compound VIII.

Preparation method of aryl propionic acid compound

-

Page/Page column 0121-0125, (2020/10/04)

The invention provides a preparation method of an aryl propionic acid compound, wherein the preparation method comprises the following steps: carrying out acetylation reaction on substituted aryl benzene to obtain aryl acetophenone; carrying out hydrogenation reduction reaction on alpha-substituted aryl ethyl ketone to obtain alpha-substituted aryl ethanol; and in an acidic solution, introducing carbon monoxide gas into the alpha-substituted aryl ethanol, and carrying out a carbonylation reaction under the co-catalytic action of a main catalyst and a cocatalyst to obtain the aryl propionic acid compound, wherein the cocatalyst has the following structural formula described in the specification, R1 is one of hydrogen and a substituted carboxylic acid group, and R2 is one of hydrogen, halogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C1-C6 alkoxy, substituted or unsubstituted C3-C12 naphthenic base, substituted carbonyl containing C6-C24 aryl or substitutedaryl, substituted carbonyl containing C3-C12 heterocyclic radical or substituted heterocyclic radical, phenyl, substituted phenyl, naphthyl and substituted naphthyl.

Synthesis method of loxoprofen sodium

-

, (2019/06/07)

The invention discloses a synthesis method of loxoprofen sodium, which comprises the following steps of: step 1), preparing N-(1-cyclopentenyl) morpholine; step 2), preparing 2-(4-bromomethyl phenyl)methyl propionate, the method also comprises the following step 3), preparing loxoprofen sodium by an enamine alkylation method: first dissolving 2-(4-bromomethyl phenyl) methyl propionate in a solvent, adding N-(1-cyclopentenyl) morpholine and the solvent in a container, dropwise adding 2-(4-bromomethyl phenyl) methyl propionate solution under reflux conditions; continuing reacting under reflux conditions after the completion of the dropwise addition; adding alkali solution after obtained reaction liquid is cooled, hydrolysising and separating to obtain an organic phase and an aqueous phase respectively, extracting the aqueous phase with an extractant to obtain extract liquid and the aqueous phase after extraction respectively, and post-treating the aqueous phase after extraction to obtain loxoprofen sodium. The preparation of loxoprofen sodium by the above method has the advantages of simple reaction steps, high yield of loxoprofen sodium and low production cost.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68767-14-6